Advaxia Biologics

Scientific Leadership

Vaccine-filled vials lined up on expert assembly machine ready for labels

Scientific Leadership

Home » About Us » Scientific Leadership


Dr. Stefania Di Marco, Ph.D.

Qualified Person and Scientific Director

12-year GMP experience in production, testing and release of biological investigational medicinal products for infectious diseases (HCV, malaria, RSV, HIV, Ebola, leishmaniasis, rabies, HBV, RVF and SARS-CoV-2) and investigational gene therapy products for cancer.

Author of 57 peer-reviewed publications and inventor of four patents.

12-year experience in the evaluation and review/monitoring of EU-funded research programmes: FP7, H2020 and HORIZON proposals; Eureka-Eurostars proposals; Innovation Fund Denmark Peer Review.

18-year research experience in preclinical drug discovery and development, employing molecular biology, biochemistry and X-ray crystallography for functional studies and structure-based drug design (six years at Novartis, Basel; twelve years at IRBM-Merck, Pomezia-Roma). Main research subjects have been medically relevant protein targets in several therapeutic areas, like Infectious Diseases, Anti-Thrombotics, Cardiovascular and Oncology.

Dr. Stefania Di Marco, presenting on the topic of Viral Vaccines at World Vaccine Congress 2022 in Barcelona, Spain.

Contact Our Scientific LeaderSHIP

We would love to hear from you.

Skip to content